Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Biomarker Analyses from the Phase 3 Randomized CLEAR Trial: Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma

R.J. Motzer,C. Porta,M. Eto,T.E. Hutson,S.Y. Rha,J.R. Merchan,E. Winquist,H. Gurney,V. Grünwald,S. George, J. Markensohn,J.E. Burgents,R. Cristescu,P. Sachdev, Y. Narita, J. Huang, Z. Zhao,C.E. Okpara,Y. Minoshima,T.K. Choueiri

Annals of Oncology（2024）

Cited 0|Views4
Key words
Biomarkers,lenvatinib,pembrolizumab,CLEAR,RCC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined